Ann: NYX-PCSK9i In Vivo Study Exploratory Analysis Results, page-27

  1. 603 Posts.
    lightbulb Created with Sketch. 269
    I do love when people call a Coy rubbish then disclose they hold - low risk tolerance maybe?

    Whole market has been sold off this week and NYR has been holding 28.5c support for months, was only going to take one impatient holder to push down through the support, it is so thinly traded.

    One needs patience in biotech land while holding out for results (i.e. limited news flow short term).

    As a long term holder I don't care about todays price action, or next weeks. TBH, bring me 20c so I can double my holding.

    All I can think of with this is, using the same study that originally indicated Atorvastatin (Lipitor) Efficacy and Safety, NYR has identified a superior compound.... DYOR....

    Anyway, starting to sound like a broken record on the buy side so ill shut my trap now.

    GLTAH.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.010(4.26%)
Mkt cap ! $51.67M
Open High Low Value Volume
23.0¢ 25.0¢ 23.0¢ $143.6K 590.6K

Buyers (Bids)

No. Vol. Price($)
1 60000 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 159081 1
View Market Depth
Last trade - 15.59pm 20/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.